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Percentiles of fasting serum insulin, glucose, HbA1c
and HOMA-IR in pre-pubertal normal weight European
children from the IDEFICS cohort
J Peplies1, D Jiménez-Pavón2, SC Savva3, C Buck1, K Günther1, A Fraterman4, P Russo5, L Iacoviello6, T Veidebaum7, M Tornaritis3,
S De Henauw8, S Mårild9, D Molnár10, LA Moreno2 and W Ahrens1,11 on behalf of the IDEFICS consortium
OBJECTIVES: The aim of this study is to present age- and sex-speciﬁc reference values of insulin, glucose, glycosylated
haemoglobin (HbA1c) and the homeostasis model assessment to quantify insulin resistance (HOMA-IR) for pre-pubertal children.
METHODS: The reference population consists of 7074 normal weight 3- to 10.9-year-old pre-pubertal children from eight European
countries who participated in at least one wave of the IDEFICS (‘identiﬁcation and prevention of dietary- and lifestyle-induced
health effects in children and infants’) surveys (2007–2010) and for whom standardised laboratory measurements were obtained.
Percentile curves of insulin (measured by an electrochemiluminescence immunoassay), glucose, HbA1c and HOMA-IR were
calculated as a function of age stratiﬁed by sex using the general additive model for location scale and shape (GAMLSS) method.
RESULTS: Levels of insulin, fasting glucose and HOMA-IR continuously show an increasing trend with age, whereas HbA1c shows
an upward trend only beyond the age of 8 years. Insulin and HOMA-IR values are higher in girls of all age groups, whereas glucose
values are slightly higher in boys. Median serum levels of insulin range from 17.4 and 13.2 pmol l− 1 in 3–< 3.5-year-old girls and
boys, respectively, to 53.5 and 43.0 pmol l− 1 in 10.5–< 11-year-old girls and boys. Median values of glucose are 4.3 and
4.5 mmol l− 1 in the youngest age group and 49.3 and 50.6 mmol l− 1 in the oldest girls and boys. For HOMA-IR, median values
range from 0.5 and 0.4 in 3–< 3.5-year-old girls and boys to 1.7 and 1.4 in 10.5–< 11-year-old girls and boys, respectively.
CONCLUSIONS: Our study provides the ﬁrst standardised reference values for an international European children’s population and
provides the, up to now, largest data set of healthy pre-pubertal children to model reference percentiles for markers of insulin
resistance. Our cohort shows higher values of Hb1Ac as compared with a single Swedish study while our percentiles for the
other glucose metabolic markers are in good accordance with previous studies.
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INTRODUCTION
Insulin resistance is one of the most common metabolic
alterations related to obesity.1,2 It represents a key element of
the metabolic syndrome and an important link between obesity
and other metabolic as well as cardiovascular complications.3,4
Children with insulin resistance are also at risk for type 2 diabetes5
and a high proportion of cases apparently remain undiagnosed
initially.6
Although reference data for body mass index (BMI) were
published by organisations like International Obesity Taskforce,
World Health Organization, Centers for Disease Control and
Prevention and many others and these are widely used in
paediatrics, there is still a lack of adequate reference data for
markers of insulin resistance.7 Fasting insulin and homeostasis
model assessment to quantify insulin resistance (HOMA-IR) have
been suggested among others as surrogate markers for screening
purposes in adults,8 as the gold standard method to measure
insulin sensitivity (the hyperinsulinaemic euglycaemic clamp) is
very labour- and time-intensive and thus not feasible in
epidemiological research. Oral glucose tolerance testing, a
procedure widely used to measure insulin response in clinical
practice, is also not feasible in a setting-based ﬁeld study like ours.
Matthews et al.9 showed that estimates of insulin resistance from
HOMA-IR correlated well with estimates from the clamp-
technique. Glycosylated haemoglobin (HbA1c) is a standard
marker for glycaemic control in diabetic patients but has also
been proposed as a predictive marker of insulin resistance.8
Population-based data on insulin resistance in children are rare,
especially for pre-pubertal children and from large-scale epide-
miological studies. Several authors have shown data on the
distribution of insulin, glucose and HOMA-IR values in paediatric
populations, and some also suggested cut-off values for insulin
and HOMA-IR.10–17 However, all of these studies were limited to
national study populations and sample sizes were mostly too
small for statistical modelling of reference values. None of the
studies included > 1000 pre-pubertal children, except for a
Mexican cross-section with about 2500 children in the age
stratum of 6–10 years.13 All authors describe a pronounced age
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dependency of insulin and HOMA-IR, and to a lesser extent also of
glucose values. Studies in adolescents show a peak of insulin and
HOMA-IR values in puberty and again a slight decline towards
adulthood.10,13,18 Comparability of results is limited due to the
multitude of different laboratory procedures (for example,
enzyme-linked immunosorbent assay, radioimmunoassay, immu-
noenzymometric assay, immunoelectrochemiluminometric assay)
used for the determination of insulin. These different assays can
show up to a twofold variation in insulin concentrations.19
The aim of this study is to present age- and sex-speciﬁc
reference values for insulin, glucose and HOMA-IR based on a
European population of normal weight pre-pubertal children from
eight European countries who participated in at least one wave
of the IDEFICS (‘identiﬁcation and prevention of dietary- and
lifestyle-induced health effects in children and infants’) surveys
(2007–2010) and received standardised examinations and labora-
tory measurements.
MATERIALS AND METHODS
Study population
A population-based prospective cohort study was one of the key elements
of the IDEFICS project. All children of the deﬁned age group who lived in
the selected study regions and attended one of the participating pre- or
primary schools were eligible for participation. Children and parents were
approached via schools and preschools to ensure inclusion of all social
groups. Written consent of parents and verbal assent of children were
given separately to the different modules of the examination, that is,
participants were free to refrain from single components like blood
drawing.
The baseline survey in the school year 2007/2008 included 16 228
preschool and primary school children aged 2–9 years from eight
European countries (Belgium, Cyprus, Estonia, Germany, Hungary, Italy,
Spain and Sweden). Of these, 11 292 were followed up again after 2 years.
In the follow-up survey (2009–2010), 2517 new children were additionally
included.
Both waves of surveys comprised anthropometrical measurements and
examinations of children as well as parental self-completion questionnaires
on lifestyle habits and dietary intakes of children. The physical examination
programme during the IDEFICS surveys covered standard anthropometric
measures, that is, height, weight and circumferences of waist, hip, upper
arm and neck, as well as skinfold thicknesses, and the measurement of
blood pressure and pulse rate. BMI was calculated as weight (in kg) divided
by height squared (in m) and classiﬁed according to the International
Obesity Taskforce criteria.20
Biomarkers were analysed in blood, urine and saliva samples.
Standardised procedures were used by all survey centres and a quality
management system was established.21 Venous blood was collected after
an overnight fast from 9185 of the baseline and 962 of the children newly
recruited at follow-up. In addition, 1011 children who did not provide
blood at baseline survey, provided blood at follow-up. The present
analyses included children of both waves of surveys with available data
for height, weight and the laboratory analyses of interest. If serum
measurements of a child were available for both survey waves, preference
was given to the baseline survey. Girls and boys below 3 and above 10.9
years of age were excluded from the study sample due to the small
number of children in these age strata (n< 100) to avoid instability of the
statistical model. Children were also excluded if they had a diagnosis of
diabetes or if they reported to be non-fasting at the time of blood
withdrawal. The present analysis is thus based on 7074 children, as
depicted in Figure 1. The background of the IDEFICS study, its research
goals and instruments have been described elsewhere in detail.22
Laboratory analyses
Children participating in the IDEFICS baseline survey were asked to provide
fasting venous blood, morning urine and saliva samples. If consent was not
given for venous blood withdrawal, capillary blood was taken with
the consent of the parents and the children. Blood glucose was assessed
on site at each study centre by point-of-care analysis using the Cholestech
LDX analyser (Cholestech, Cholestech Corp., Hayward, CA, USA) either in
venous or capillary blood. Precision and accuracy of this analyser were
comparable to clinical diagnostic laboratory methods23 with a slight
positive bias of glucose measurement.24 Pre-analytical sample processing
of blood samples was done at the local survey centres or at local
laboratories. Samples were then frozen (at − 80 °C) and shipped to a central
laboratory, certiﬁed by ISO 15189:2007, for later analysis of insulin, HbA1c
and other biological markers. Insulin was analysed by an electrochemilu-
minescence immunoassay (Roche Modular System, Mannheim, Germany),
HbA1c was analysed by high-performance liquid chromatography (AUTO-
GA variant). Details on the biological sampling procedures can be obtained
from an earlier publication.25 HOMA-IR was calculated as fasting insulin
(μIU ml− 1) × fasting glucose (mmol l− 1)/22.5.
Statistical analyses
Percentile curves of insulin, glucose and HOMA-IR were calculated as a
function of the covariate age stratiﬁed by sex using general additive model
for location scale and shape (GAMLSS) method as an extension of the LMS
method.26 The LMS method models three parameters: the skewness L, the
median M and the coefﬁcient of variation S. The skewness accounts for
the deviation from a normal distribution using a Box–Cox transformation,
the median of the outcome variable is modelled depending on one
explanatory variable and the coefﬁcient of variation accounts for the
variation of data points around the mean and adjusts for non-uniform
dispersion. The GAMLSS method is able to model more than one covariate
and also other distributions that particularly include the kurtosis. We used
the gamlss package (version 4.2–6) of the statistical software R (version
3.0.1).27 Different distributions were ﬁtted to the observed distribution of
insulin, glucose and HOMA-IR. Moreover, the inﬂuence of age on
parameters of the considered distributions were modelled either as a
constant, as a linear function, or as a cubic spline of the covariates.
Goodness-of-ﬁt was assessed by the Bayesian information criterion and by
Q–Q plots to select the ﬁnal model including the ﬁtted distribution of
insulin, glucose and HOMA-IR and the inﬂuence of covariates on
distribution parameters. Worm plots were used as a diagnostic tool to
assess whether adjustment for kurtosis was required.28 Finally, percentile
curves for the 5th, 10th, 25th, 50th, 75th, 90th and 95th were calculated
based on the model that showed the best ﬁt.27,29
The ﬁnal models for insulin and HOMA-IR for boys and girls considered a
Box–Cox t (BCT) distribution modelling μ as a cubic spline depending on
age, log(σ) as a linear function of age, and ν and τ as constants. With regard
to glucose, a lognormal distribution was used for boys and girls
considering μ as a linear function of age and log(σ) as a constant.
Figure 1. Flow chart of children included in the analysis.
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RESULTS
The reference population is composed of 3434 girls and 3640
boys. One-year age groups (3.0–10.9 years of age) include from
about 250 up to 1500 children. Characteristics of this population
are presented as mean values (± s.d.) or median (25th, 75th
percentile) by age group in Table 1 for the study population
before and after restriction to normal weight children. Anthro-
pometrical measures and glucose concentrations show only little
differences between boys and girls, but insulin concentrations are
higher in girls than in boys through all age groups, which is also
reﬂected in slightly higher HOMA-IR values.
Percentiles of insulin, glucose and HOMA-IR are presented in
half-year age groups in Table 2 and Figures 2–4, respectively.
Concentrations of all three biomarkers clearly show a positive
trend with age, which is also observed for the variance of insulin
and HOMA-IR, whereas for glucose the variance is similar in all age
groups. Insulin and HOMA-IR values are higher in girls than in boys
for all age groups, whereas glucose values are slightly higher
in boys.
For insulin, 5th and 95th percentiles range from 4.2–49.3 and
3.5–41.0 pmol l−1 in 3–< 3.5-year-old girls and boys, respectively,
to 25.7–100.7 and 19.4–88.2 pmol l− 1 in 10.5–< 11-year-old girls
and boys. For glucose, 5th and 95th percentiles were 3.6–5.2 and
3.7–5.3 mmol l− 1 in 3–< 3.5-year-old girls and boys up to 4.2–5.7
and 4.3–5.9 mmol l− 1 in 10.5–< 11-year-old girls and boys. For
HOMA-IR, 5th and 95th percentiles ranged from 0.1–1.5 and
0.1–1.3 in 3–< 3.5-year-old girls and boys to 0.8–3.4 and 0.6–3.0 in
10.5–< 11-year-old girls and boys.
A table showing percentiles for children of all weight groups is
provided in Supplementary Table A. Percentile values for glucose
show only negligible differences as compared with the values for
normal weight children. Inclusion of overweight and obese
children has little impact on lower percentiles of insulin and
HOMA-IR but has a very pronounced effect on the upper
percentiles, especially in the older age groups. The 95th percentile
of insulin in 10.5–< 11-year-old girls for instance, is 125.7
compared with 100.7 pmol l− 1 in normal weight girls of the same
age. A sensitivity analysis was conducted to illustrate the inﬂuence
of BMI on age-speciﬁc values of insulin, glucose and HOMA-IR.
A strong dependency on weight status was observed for insulin
and HOMA-IR but not for glucose. Insulin percentile curves for
children of all weight groups versus only normal weight girls and
boys are depicted in Figure 5. Results of the sensitivity analyses for
glucose and HOMA-IR are provided in Supplementary Figures
A and B. Three different reference populations for BMI were used
to test the robustness of the model.20,30–32 Preference was given
to the classiﬁcation by Cole et al.,20 as differences between the
three reference systems were not substantial and this classiﬁcation
led to the smallest number of excluded children.
Percentile curves for HbA1c are provided in Supplementary
Figure C. Serum concentrations show nearly no variation for
younger children (median of 26.8 for girls and 27.9 mmol mol− 1
for boys at 3 years of age to 29.0 mmol mol− 1 for both sexes at 8
years of age) and a slight increase for the 8–< 11-year-old children
(median of 34.4 mmol mol− 1 for girls and 33.3 mmol mol− 1 for
boys at 10.9 years of age).
DISCUSSION
This study presents age- and sex-speciﬁc reference percentiles of
insulin, glucose and HOMA-IR for pre-pubertal children on the
basis of the IDEFICS cohort of children from eight European
countries. This is the ﬁrst time, reference percentiles of these
biomarkers are based on a multinational children’s cohort. At the
same time, with over 7000 subjects, it is by far the biggest cohort
ever used to generate such reference data. Nevertheless, previous
studies of local populations have shown similar distributions of
insulin, glucose and HOMA-IR values in children. As the age group
of 9-year-olds was considered most frequently, this age group
will be used for comparison in the following.
In our reference population the 5th and 95th percentile values
of insulin are 15.3–81.3 pmol l− 1 for 8.5–< 9.5-year-old girls and
12.5–74.3 pmol l− 1 for 8.5–< 9.5-year-old boys. Insulin values were
also measured in a representative sample of 2244 school children
from Quebec who were 9, 13, and 16 years old in 1999 (ref. 11)
(insulin measured by the ultrasensitive insulin assay on the Access
immunoassay system by Beckman Coulter, Mississauga, ON,
Canada), in a representative sample of 1976 healthy French
individuals aged 7–20 years in 2006–2008 (ref. 12) (insulin
measured with a microparticle enzymoimmuno assay on an
AxSYM analyser by Abbott, Abbott Park, IL, USA) and in a random
sample of 1137 healthy 9- and 15-year-old school children
examined in a cross-sectional study in Sweden in 1998/99
(ref. 17) (insulin assay not reported). In the pre-pubertal group
of 9-year-olds, the 5th and 95th percentiles of insulin were
11.8–59.0,11 13.9–83.3 (ref. 12) and 11.1–78.5 pmol l− 1 (ref. 17) in
girls and 10.4–54.2,11 10.4–69.5 (ref. 12) and 10.4–64.6 pmol l− 1 in
boys. Overall, insulin concentrations were showing a positive
trend with age until puberty and revealed pubertal peaks, which
were sharper in females than in males. These results are in good
accordance with the percentile values from our study. Studies in
mixed non-Caucasian populations on 6132 school children aged
6–18 years in Mexico13 (insulin measured with a microparticle
enzymoimmuno assay on an AxSYM analyser by Abbott) and 2153
normal weight children and adolescents in Chile16 (insulin
measured by chemiluminescence on the ADVIA Centaur
CP Immunoassay System, Bayer HealthCare AG, Leverkusen,
Germany) also showed a gradual increase of insulin values
between 6 and 13 years of life. Possibly due to the fact that older
children were included, insulin concentrations were higher in the
Chilean population than in our study cohort: the 5th and 95th
percentiles were 29.9–150.0 pmol l− 1 for girls and 26.4–117.4-
pmol l− 1 for boys in Tanner stages I and II.16
For glucose, the 5th and 95th reference percentiles in our
population are 4.0–5.6 mmol l− 1 for 8.5–< 9.5-year-old girls and
4.1–5.8 mmol l− 1 for 8.5–< 9.5-year-old boys. Remarkably, glucose
curves showed a linear trend in this pre-pubertal age group.
To verify linearity of this functional relationship, we also applied a
cubic model to the data. As both curves looked very similar, we
preferred to use the simpler model. In addition, we know from
literature12 that glucose curves only start to ﬂatten during puberty,
which may lead to a linear functional relationship for the age
range that we have considered here. Glucose values were very
similar in the three above-mentioned studies from Canada,11
France12 and Sweden.17 For 9-year-olds, the 5th and 95th
percentiles were 4.4–5.6,11 3.9–5.2 (ref. 12) and 4.3–5.4 mmol l− 1
(ref. 17) in girls and 4.7–5.7,11 4.0–5.2 (ref. 12) and 4.4–5.5
mmol l− 1 (ref. 17) in boys. Percentile values of glucose showed a
positive trend with age, although the trend was less pronounced
as compared with insulin. A distinct pubertal peak of serum
glucose concentrations was only observed in females.
For HOMA-IR, the 5th and 95th percentiles in our reference
population are 0.4–2.7 for 8.5–< 9.5-year-old girls and 0.4–2.5 for
boys of this age. Estimates from the 1999 Quebec sample11
(insulin measured by the ultrasensitive insulin assay on the Access
immunoassay system by Beckman Coulter) showed slightly lower
HOMA-IR values (5th and 95th percentile) of 0.3–2.1 and 0.3–1.9
for 9-year-old girls and boys, respectively. A small Italian cross-
section of healthy children and adolescents reported values of
0.6–2.2 for pre-pubertal girls and 0.4–2.2 for the respective boys15
(insulin measured by radioimmunoassay, Radim Kit, Rome, Italy).
The above-mentioned studies in Mexico13 (insulin measured with
a microparticle enzymoimmuno assay on an AxSYM analyser
by Abbott) and Chile16 (insulin measured by chemiluminescence
on the ADVIA Centaur CP Immunoassay System, Bayer
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HealthCare AG) also showed an increase of HOMA-IR from the age
of 6 to the age 13 years. Similar to insulin, percentile values were
obviously higher for the combined group of Tanner stages I and II,
as compared with our study population, that is, HOMA-IR values
were 0.9–4.9 for girls and 0.8–3.9 for boys. A HOMA-IR value of 2.0
was suggested as a cut-off point for pre-pubertal children in a
population-based small Italian study14 (insulin measured by an
immunoenzymometric assay, AIA-Pack IRI, Tosoh, Tokyo, Japan).
Cut-off values were also derived from oral glucose tolerance
testing in studies with obese children. Two Turkish studies on 148
and 82 obese paediatric patients, proposed cut-off points of
HOMA-IR ⩾ 2.7 for both sexes33 (insulin was measured using the
IMMULITE immunoassay, IMMULITE Diagnostic Products Corpora-
tion, Los Angeles, CA, USA) or HOMA-IR ⩾ 2.2 for girls and ⩾ 2.7 for
boys34 (insulin measured by an immunoradiometric assay kit,
INS-Irma Biosource, Nivelles, Belgium).
HbA1c as a standard marker for glycaemic control in diabetes
has rather little relevance in healthy children. However, as it is
frequently measured in population-based studies, we included it
in our analysis and we present the results in Supplementary Figure
C. To our knowledge, there is only one recent study that aimed to
deﬁne paediatric reference values for HbA1c.35 This Swedish
cohort investigated healthy children from 6 months to 18 years
of age and suggested cut-off values of 16.9–27.9 mmol mol− 1
(2.5th and 97.5th percentile), which are lower than the 5th and
95th percentiles observed in our study population, that is,
15.8–34.4 and 16.9–34.4 mmol mol− 1 for 3-year-old girls and boys,
and up to 26.8–38.8 and 15.8–39.9 mmol mol− 1 for 10.9-year-old
girls and boys.
Overall, the distributions of insulin, glucose and HOMA-IR
shown in previous studies are in good accordance with the
reference percentiles in the present analysis. For the subgroup of
9-year-old girls and boys, the 5th and 95th percentile values are
very similar to cohorts from European countries or Canada.
Concentrations were generally higher in countries with mixed
populations including people with indigenous ancestry or when
Figure 2. Percentiles of fasting serum insulin (measured by an electrochemiluminescence immunoassay) from normal weight children of the
IDEFICS cohort (2007–2010).
Figure 3. Percentiles of fasting blood glucose (measured by point-of-care analysis) from normal weight children of the IDEFICS cohort
(2007–2010).
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adolescents were included (for example, combined analysis for
Tanner stages I and II), which corresponds well with the pubertal
peak described for all of the considered markers. Differences in
insulin and HOMA-IR levels could also be due to the variety of
different insulin assays used in the referenced studies.
In our study, only normal weight children were included into
the modelling of percentile curves as the insulin level is known to
be strongly inﬂuenced by BMI.36 Despite the strong inﬂuence of
BMI on markers of insulin resistance, the relationship between BMI
and HOMA-IR has been shown to be much weaker in children than
in adults.37 Within the growing group of children with overweight
and obesity, paediatricians are faced with the challenge of
identifying individuals at the greatest risk of comorbidity. It has
been pointed out by other authors that interventions to halt
weight gain and promote weight loss in children are of limited
success and demand signiﬁcant resources and continuous follow-
up and monitoring.38 This puts the caregiver in the dilemma of
where to allocate the limited available resources and who among
the obese children will beneﬁt most from an intervention.1 The
provision of paediatric reference curves for insulin resistance is
thus long overdue.
The main strengths of the present study are the large sample
size and the standardised assessment of anthropometrical and
laboratory measurements. The statistical modelling was done
according to the most advanced methodology, which has also
been used by the most recent studies in this ﬁeld.29,39,40 Some
limitations of the study should also be accounted for: even though
the study was designed to reach all eligible children in the
selected study regions via their settings, the overall participation
rate was just above 50%,22 and a non-response bias, for example,
towards higher social status may well be present. Nevertheless,
the inﬂuence of social status on insulin resistance is likely to be
mediated by weight status, which is one of the reasons why we
restricted our analyses to normal weight children. Another
Figure 4. Percentiles of HOMA-IR from normal weight children of the IDEFICS cohort (2007–2010). Insulin was measured by an
electrochemiluminescence immunoassay, glucose was measured by point-of-care analysis.
Figure 5. Sensitivity analysis showing percentiles of fasting serum insulin according to different deﬁnitions of normal weight and for the
whole study group including children of all weight groups (classiﬁcation of normal weight according to Cole et al./International Obesity
Taskforce,20 Centers for Disease Control and Prevention30 and World Health Organization31,32).
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problem might be caused by the fact that pubertal stages were
not assessed in the IDEFICS surveys. Even though children of our
age range are considered to be pre-pubertal, we cannot exclude
that a few of them might already have developed signs of
beginning puberty that might better be excluded from the
reference population.
In summary, the reference percentiles presented here are to our
knowledge the ﬁrst to be based on a multinational children’s
population that is also the largest cohort that was up to now used
to model reference percentiles for markers of insulin resistance
(insulin measured by electrochemiluminescence immunoassay).
These reference values may help to identify children with insulin
resistance who have an elevated risk for cardiovascular disease
and type 2 diabetes mellitus. These reference values will thus
allow for a more focused and earlier behavioural or therapeutic
intervention. As insulin resistance has been shown to be reversible
in most cases by healthy eating and physical activity,41,42 these
reference values may hopefully contribute to reduce the burden
of disease in the long run.
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